Literature DB >> 4048087

Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia.

R Michielutte, R A Diseker, L D Young, W J May.   

Abstract

This investigation estimated the extent of noncompliance with follow-up to screening for cervical dysplasia at a public health family planning clinic. Available data also permitted examination of the relationship between selected background characteristics and compliance with follow-up. Noncompliance was defined as failure to respond to notification of an abnormal cervical smear (Class III, IV, or V) by failing either to make a follow-up appointment or to keep such an appointment after it was made. The sample consisted of 177 women with abnormal cervical smears who were screened at the Forsyth County Family Planning Clinic between January 1, 1980, and June 30, 1981. Information on the women's compliance with the request for follow-up was obtained from a file specifically kept for this purpose by the clinic nurse. Background characteristics were obtained by reviewing clinic records. Results indicated that approximately 17% of the sample was noncompliant. Noncompliant patients were more likely to be unmarried, less educated, younger, and to have fewer total health problems than women who returned for follow-up. Logistic regression analysis revealed that the number of health problems and educational attainment were the most important predictors of noncompliance.

Entities:  

Mesh:

Year:  1985        PMID: 4048087     DOI: 10.1016/0091-7435(85)90040-4

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  17 in total

1.  Inadequate follow-up for abnormal Pap smears in an urban population.

Authors:  Neeraja B Peterson; Jini Han; Karen M Freund
Journal:  J Natl Med Assoc       Date:  2003-09       Impact factor: 1.798

Review 2.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

3.  The costs and effects of cervical and breast cancer screening in a public hospital emergency room. The Cancer Control Center of Harlem.

Authors:  J Mandelblatt; H Freeman; D Winczewski; K Cagney; S Williams; R Trowers; J Tang; K Gold; T H Lin; J Kerner
Journal:  Am J Public Health       Date:  1997-07       Impact factor: 9.308

4.  Identification of community leadership in the development of public health education programs.

Authors:  R Michielutte; P Beal
Journal:  J Community Health       Date:  1990-02

5.  Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic.

Authors:  Faith E Fletcher; Meredith Buchberg; Leslie R Schover; Karen Basen-Engquist; Mirjam-Colette Kempf; Roberto C Arduino; Damon J Vidrine
Journal:  AIDS Care       Date:  2014-03-18

6.  Development of a community cancer education program: the Forsyth County, NC cervical cancer prevention project.

Authors:  R Michielutte; M B Dignan; H B Wells; L D Young; D S Jackson; P C Sharp
Journal:  Public Health Rep       Date:  1989 Nov-Dec       Impact factor: 2.792

7.  A theory-based approach to understanding follow-up of abnormal Pap tests.

Authors:  Carmen Radecki Breitkopf; Heidi C Pearson
Journal:  J Health Psychol       Date:  2009-04

8.  Effect of health beliefs on delays in care for abnormal cervical cytology in a multi-ethnic population.

Authors:  Karin Nelson; Ann M Geiger; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

9.  Variations in practice guideline adherence for abnormal cervical cytology in a county healthcare system.

Authors:  Rita Singhal; Lisa V Rubenstein; Mingming Wang; Martin L Lee; Anwar Raza; Christine H Holschneider
Journal:  J Gen Intern Med       Date:  2008-02-20       Impact factor: 5.128

10.  Peer navigation improves diagnostic follow-up after breast cancer screening among Korean American women: results of a randomized trial.

Authors:  Annette E Maxwell; Angela M Jo; Catherine M Crespi; Madhuri Sudan; Roshan Bastani
Journal:  Cancer Causes Control       Date:  2010-07-31       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.